HYSFLOGEND: New Alternatives for improving the treatment of Asthma and Bronchitis.
This invention relates to the field of health, especially with the allergy, and is developing a product obtained from the mixture of plants that acts in the stabilization of the functions of the bronchial tree, both on a preventive and abortive acute asthma behaving like an anti-inflammatory and antihistamine. This product is an essential aid in the therapeutic treatment of obstructive respiratory diseases, especially asthma and bronchitis.
The state HYSFLOGEND product development is complete, was studied and provided to patients with conditions such as asthma, bronchitis and asthmatic bronchitis that included children, adults and seniors.
Is an oral product that has sustained efficacy, excellent safety, tolerability and easy dosage, where the results indicate that treatment in humans is a positive balance for the health of patients with these diseases diagnosed, contributing to therapeutic success and with fewer side effects than current options in the market, greater tolerance and clinically proven effectiveness with comprehensive safety profile.